Cite
HARVARD Citation
Ciriaco, N. et al. (2022). Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response. Therapeutic advances in medical oncology. p. . [Online].